Faraday Pharmaceuticals

Faraday Pharmaceuticals, Inc. was a Seattle, Washington clinical-stage biopharmaceutical company founded in 2014 as a spinout of Fred Hutchinson Cancer Center, built on the elemental-reducing-agent research of Dr. Mark Roth. It developed therapies intended to prevent and treat cardiac and skeletal muscle loss after acute critical illness, led by FDY-5301 — a proprietary intravenous formulation of sodium iodide designed to neutralize reactive oxygen species and limit reperfusion injury in patients undergoing percutaneous coronary intervention for anterior ST-elevation myocardial infarction (STEMI). The company raised roughly $120M from an investor group led by ARCH Venture Partners and Polaris Partners. Its Phase 3 trial read out in late 2025 and failed to meet its primary or secondary endpoints, and Faraday announced in February 2026 that it had ceased operations and was winding down the business. Faraday never operated a developer program, public API, SDK, or machine-readable specification, and its faradaypharma.com website is no longer served. This profile is retained as a historical record; there is no API surface to enrich.

Faraday Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Clinical Trials.

📡 Source on GitHub
0 APIs
CompanyPharmaceuticalsBiotechnologyLife SciencesClinical TrialsClinical StageCardiologyDrug DevelopmentDefunct

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Faraday Pharmaceuticals Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

LinkedIn
LinkedIn

Other 1

Properties that don't map to a standard resource type

SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: faraday-pharmaceuticals
name: Faraday Pharmaceuticals
description: Faraday Pharmaceuticals, Inc. was a Seattle, Washington clinical-stage biopharmaceutical company founded in 2014
  as a spinout of Fred Hutchinson Cancer Center, built on the elemental-reducing-agent research of Dr. Mark Roth. It developed
  therapies intended to prevent and treat cardiac and skeletal muscle loss after acute critical illness, led by FDY-5301 —
  a proprietary intravenous formulation of sodium iodide designed to neutralize reactive oxygen species and limit reperfusion
  injury in patients undergoing percutaneous coronary intervention for anterior ST-elevation myocardial infarction (STEMI).
  The company raised roughly $120M from an investor group led by ARCH Venture Partners and Polaris Partners. Its Phase 3 trial
  read out in late 2025 and failed to meet its primary or secondary endpoints, and Faraday announced in February 2026 that
  it had ceased operations and was winding down the business. Faraday never operated a developer program, public API, SDK,
  or machine-readable specification, and its faradaypharma.com website is no longer served. This profile is retained as a
  historical record; there is no API surface to enrich.
url: https://raw.githubusercontent.com/api-evangelist/faraday-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: defunct-no-api-surface
x-status: defunct
x-founded: '2014'
x-shutdown-date: 2026-02
x-shutdown-reason: FDY-5301 Phase 3 missed its primary and secondary endpoints; the company announced in February 2026 that
  it had ceased operations and was winding down.
x-domain-status: expired-hosting
x-domain-note: faradaypharma.com still resolves to Squarespace and retains live SPF/DMARC mail records, but every path — including
  / — returns HTTP 404 with the Squarespace "Website Expired" page. The domain is deliberately NOT wired as a Website pointer
  because it no longer serves company content.
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
specificationVersion: '0.23'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Clinical Trials
- Clinical Stage
- Cardiology
- Drug Development
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: LinkedIn
  url: https://www.linkedin.com/company/faradaypharma
- type: SecondaryMarket
  url: https://forgeglobal.com/faraday-pharmaceuticals_stock/
- type: DomainSecurity
  url: security/faraday-pharmaceuticals-domain-security.yml
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 3
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider 
curl "https://apis.io/api/v1/providers/faraday-pharmaceuticals"
All providers 
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose 
curl "https://apis.io/api/v1/providers/faraday-pharmaceuticals/operations?limit=25"
How their score was established 
curl "https://apis.io/api/v1/providers/faraday-pharmaceuticals/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.